Collegium Pharmaceutical, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of COLL for the last quarter is 145.28 M USD, and it's 0.24% higher compared to the previous quarter. The net income of Q2 24 is 19.61 M USD.